Interestingly, the IL-6/JAK/STAT3 and complement pathways were the most highly upregulated genes in Group 2 (Fig. S3), inferring an association with immune activation and cancer metastasis control, which is not reported in the BL2 subtype. This evidence concerns the gene IL6 and cancer.